Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

8 results
Display

Activin A Stimulates Mouse APCs to Express BAFF via ALK4-Smad3 Pathway

Kim JH, Seo GY, Kim PH

BACKGROUND: B cell-activating factor belonging to the TNF family (BAFF) is primarily expressed by macrophages and dendritic cells, and stimulates B cell proliferation, differentiation, survival, and Ig production. In the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Activin Receptor-Like Kinase 5 Inhibitor Attenuates Fibrosis in Fibroblasts Derived from Peyronie's Plaque

Jang JH, Ryu JK, Suh JK

PURPOSE: Transforming growth factor-beta1 (TGF-beta1) is the key fibrogenic cytokine associated with Peyronie's disease (PD). The aim of this study was to determine the antifibrotic effect of 3-((5-(6-Methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl) methyl)benzamide (IN-1130),...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Transforming Growth Factor-beta Type I Receptor Inhibitor Induces Functional and Morphologic Recovery in a Rat Model of Erectile Dysfunction and Cavernous Fibrosis

Ryu JK, Oh SM, Jin HR, Song KM, Kwon MH, Kim DK, Suh JK

PURPOSE: To examine the effectiveness of small-molecule inhibitor of transforming growth factor-beta (TGF-beta) type I receptor, an activin receptor-like kinase 5 (ALK5), on erectile dysfunction (ED) in a rat model...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of IN-1130, a Novel Transforming Growth Factor-beta Type I Receptor Kinase (ALK5) Inhibitor, on a Rat Model of Peyronie's Disease Induced by Repeated Intratunical Injections of Fibrin

Piao S, Tumurbaatar M, Oh JH, Park SH, Suh JK, Ryu JK

  • KMID: 2298783
  • Korean J Androl.
  • 2009 Aug;27(2):82-88.
PURPOSE: Transforming growth factor-beta1 (TGF-beta1) has been known to be involved in the pathogenesis of Peyronie's disease (PD). In the present study, we investigated the therapeutic effect of IN-1130, a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
ACVR1 Gene Mutation in Sporadic Korean Patients with Fibrodysplasia Ossificans Progressiva

Lee DY, Cho TJ, Lee HR, Park MS, Yoo WJ, Chung CY, Choi IH

Fibrodysplasia ossificans progressiva (FOP; OMIM 135100) is a rare but extremely disabling genetic disorder of the skeletal system, and is characterized by the progressive development of ectopic ossification of skeletal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Features and Mutations in the ENG, ACVRL1, and SMAD4 genes in Korean Patients with Hereditary Hemorrhagic Telangiectasia

Lee ST, Kim JA, Jang SY, Kim DK, Do YS, Suh GY, Kim JW, Ki CS

Hereditary hemorrhagic telangiectasia (HHT) is an inherited disorder that is characterized by abnormal communication between the arteries and veins in the skin, mucosa, and various organs. HHT has been reported...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Expression and Localization of the Transforming Growth Factor-beta Type I receptor and Smads in Preneoplastic Lesions during Chemical Hepatocarcinogenesis in Rats

Park DY, Lee CH, Sol MY, Suh KS, Yoon SY, Kim JW

Little is known about the involvement of Smad-related molecules in the regulation of the Transforming Growth Factor (TGF)-beta signaling pathway during hepatocarcinogenesis, particularly with respect to preneoplastic lesions of a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Osler-Weber-Rendu disease presenting with hepatocellular carcinoma: radiologic and genetic findings

Lee JH, Lee YS, Kim PN, Lee BH, Kim GW, Yoo HW, Heo NY, Lim YS, Lee HC, Chung YH, Suh DJ

This is a case report of a 68-year-old man with hepatocellular carcinoma (HCC) accompanied by hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu disease, and hepatic vascular malformation. HHT is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr